Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole timing study for heartburn control in gastroesophageal reflux
RBR-24fcn7pPhase 2Recruiting
- Sponsor
- Universidade Federal da Fronteira Sul
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pantoprazole in gastroesophageal reflux disease (GERD) and hiatal hernia (2 arms), sponsored by Universidade Federal da Fronteira Sul. Started Oct 2022; status: recruiting.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)hiatal hernia
Beyond the preview
Go deeper on RBR-24fcn7p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-24fcn7p.